Skip to main content

Table 3 The percent of lung lobe involvement (*p < 0.005 defines a significant difference)

From: Prognostic impact of CT severity score in childhood cancer with SARS-CoV-2

  All patients (N = 64) Mild (N = 45) Moderate/severe (N = 19) P value
Right upper lobe 0.001*
 0 23 (35.9%) 21 (46.68%) 2 (10.5%)
 1 23 (35.9%) 16 (35.5%) 7 (36.8%)
 2 8 (12.5%) 4 (8.8 %) 4 (21%)
 3 2 (3.12%) 1 (2.2%) 1 (5.2%)
 4 8 (12.5%) 3 (6.6 %) 5 (26.3%)
Right middle lobe 0.001*
 0 34 (53.1%) 29 (64.4%) 5 (26.3%)
 1 15 (23.4%) 10 (22.2%) 5 (26.3%)
 2 8 (12.5%) 4 (8.8 %) 4 (21%)
 3 3 (4.7%) 1 (2.2%) 2 (10.5%)
 4 4 (6.3%) 1 (2.2%) 3 (15.7%)
Left upper lobe 0.002*
 0 28 (43.75%) 24 (53.3%) 4 (21%)
 1 18 (28.12%) 13 (28.8%) 5 (26.3%)
 2 8 (12.5%) 4 (8.8%) 4 (21%)
 3 5 (7.81%) 3 (6.6%) 2 (10.5%)
 4 5 (7.81%) 1 (2.2%) 4 (21%)
Right lower lobe 0.012*
 0 9 (14.1%) 8 (17.7%) 1 (5.2%)
 1 20 (31.2%) 15 (33.3%) 5 (26.3%)
 2 15 (23.4%) 13 (28.8%) 2 (10.5%)
 3 12 (18.8%) 6 (13.3) 6 (31.5%)
 4 5 (7.81%) 5 (26.3%) 5 (26.3%)
Left lower lobe 0.006*
 0 11 (17.2%) 9 (20%) 2 (10.5%)
 1 23 (35.9%) 19 (42.2%) 4 (21%)
 2 13 (20.3%) 10 (22.2%) 3 (15.7%)
 3 9 (14.1%) 5 (11.1%) 4 (21%)
 4 8 (12.5%) 2 (4.4) % 6 (31.5%)